Guido Jürgenliemk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Guido Jürgenliemk has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Bartosz Lipowicz
Repha GmbH Biologische Arzneimittel, Alt-Godshorn 87, D-30855 Langenhagen, Germany
3 shared publications - Jörg Heilmann
Institute of Pharmaceutical Biology, University of Regensburg, Universitätsstr. 31, D-93053 Regensburg, Germany
3 shared publications - Katrin Kuck
Lehrstuhl Pharmazeutische Biologie, Universitätsstraße 31, D-93053 Regensburg, Germany
3 shared publications Matej Barbič
Institute of Pharmacy, Pharmaceutical Biology, University of Regensburg, Universitätsstr. 31, D-93053 Regensburg
2 shared publications- Thomas Jürgen Schmidt
University of Münster, Institute of Pharmaceutical Biology and Phytochemistry, PharmaCampus, Corrensstrasse 48, D-48149 Münster, Germany
2 shared publications - Anna Unterholzner
Université de Pau et des Pays de l'Adour, E2S UPPA, IPREM, CNRS, Anglet, France
1 shared publication
Latest Publications
- Open Access
Investigation of the Phenolic Profile and Chemotaxonomical Screening of Twelve Salix Species During Growing Season
The present study describes the phenolic profile of the leaves of 12 different willow species by UPLC®-RP18-PDA in terms of variability between species, years, harvest month, and among sexes. The analyzed compound classes include salicylic alcohol derivatives (SADs), caffeic acid derivatives (CADs), coumaryl alcohol glucosides (CAGs), flavan-3-ols, flavanones, flavanonols, flavones, and flavonols. Furthermore, the Salix species were chemotaxonomically classified on this basis, and correlations between the constituent classes were analyzed. The investigations indicate that the phenolic spectrum is highly species-specific but reveals no sex-specific variation. The flavan-3-ol content varied substantially among species, ranging from 2.1–36 mg/g DW and S. bicolor was determined to be a species of particular phytochemical interest, as it contained high concentrations of flavanonols (13 mg/g DM) and flavones (24 mg/g DW). Furthermore, at the end of the growth period, the secondary metabolite content was significantly higher and the compound classes CADs and flavan-3-ols were found to be significantly influenced by the harvest year. Chemotaxonomical classification revealed the separation of S. bicolor, S. purpurea, and S. caprea from the other species when compared with the generally accepted classification of the genus. This study contributes to a more comprehensive phytochemical characterization of willow species, which may support the development of willow extracts.
Open AccessInvestigation of the Phenolic Profile and Chemotaxonomical Screening of Twelve Salix Species During Growing Season
The present study describes the phenolic profile of the leaves of 12 different willow species by UPLC®-RP18-PDA in terms of variability between species, years, harvest month, and among sexes. The analyzed compound classes include salicylic alcohol derivatives (SADs), caffeic acid derivatives (CADs), coumaryl alcohol glucosides (CAGs), flavan-3-ols, flavanones, flavanonols, flavones, and flavonols. Furthermore, the Salix species were chemotaxonomically classified on this basis, and correlations between the constituent classes were analyzed. The investigations indicate that the phenolic spectrum is highly species-specific but reveals no sex-specific variation. The flavan-3-ol content varied substantially among species, ranging from 2.1–36 mg/g DW and S. bicolor was determined to be a species of particular phytochemical interest, as it contained high concentrations of flavanonols (13 mg/g DM) and flavones (24 mg/g DW). Furthermore, at the end of the growth period, the secondary metabolite content was significantly higher and the compound classes CADs and flavan-3-ols were found to be significantly influenced by the harvest year. Chemotaxonomical classification revealed the separation of S. bicolor, S. purpurea, and S. caprea from the other species when compared with the generally accepted classification of the genus. This study contributes to a more comprehensive phytochemical characterization of willow species, which may support the development of willow extracts.
- Open Access
Terpenoids from Myrrh and Their Cytotoxic Activity against HeLa Cells
The oleo–gum resin of Commiphora myrrha (Nees) Engl. has a long history of medicinal use, although many of its constituents are still unknown. In the present investigation, 34 secondary metabolites were isolated from myrrh resin using different chromatographic techniques (silica flash chromatography, CPC, and preparative HPLC) and their structures were elucidated with NMR spectroscopy, HRESIMS, CD spectroscopy, and ECD calculations. Among the isolated substances are seven sesquiterpenes (1–7), one disesquiterpene (8), and two triterpenes (23, 24), which were hitherto unknown, and numerous substances are described here for the first time for C. myrrha or the genus Commiphora. Furthermore, the effects of selected terpenes on cervix cancer cells (HeLa) were studied in an MTT-based in vitro assay. Three triterpenes were observed to be the most toxic with moderate IC50 values of 60.3 (29), 74.5 (33), and 78.9 µM (26). Due to the different activity of the structurally similar triterpenoids, the impact of different structural elements on the cytotoxic effect could be discussed and linked to the presence of a 1,2,3-trihydroxy substructure in the A ring. The influence on TNF-α dependent expression of the intercellular adhesion molecule 1 (ICAM-1) in human microvascular endothelial cells (HMEC-1) was also tested for 4–6, 9–11, 17, 18, 20, and 27 in vitro, but revealed less than 20% ICAM-1 reduction and, therefore, no significant anti-inflammatory activity.
Open AccessTerpenoids from Myrrh and Their Cytotoxic Activity against HeLa Cells
The oleo–gum resin of Commiphora myrrha (Nees) Engl. has a long history of medicinal use, although many of its constituents are still unknown. In the present investigation, 34 secondary metabolites were isolated from myrrh resin using different chromatographic techniques (silica flash chromatography, CPC, and preparative HPLC) and their structures were elucidated with NMR spectroscopy, HRESIMS, CD spectroscopy, and ECD calculations. Among the isolated substances are seven sesquiterpenes (1–7), one disesquiterpene (8), and two triterpenes (23, 24), which were hitherto unknown, and numerous substances are described here for the first time for C. myrrha or the genus Commiphora. Furthermore, the effects of selected terpenes on cervix cancer cells (HeLa) were studied in an MTT-based in vitro assay. Three triterpenes were observed to be the most toxic with moderate IC50 values of 60.3 (29), 74.5 (33), and 78.9 µM (26). Due to the different activity of the structurally similar triterpenoids, the impact of different structural elements on the cytotoxic effect could be discussed and linked to the presence of a 1,2,3-trihydroxy substructure in the A ring. The influence on TNF-α dependent expression of the intercellular adhesion molecule 1 (ICAM-1) in human microvascular endothelial cells (HMEC-1) was also tested for 4–6, 9–11, 17, 18, 20, and 27 in vitro, but revealed less than 20% ICAM-1 reduction and, therefore, no significant anti-inflammatory activity.
- Open Access
Sesquiterpenes from Myrrh and Their ICAM-1 Inhibitory Activity In Vitro
By using various chromatographic steps (silica flash, CPC, preparative HPLC), 16 sesquiterpenes could be isolated from an ethanolic extract of myrrh resin. Their chemical structures were elucidated by 1D and 2D NMR spectroscopy and HRESIMS. Among them, six previously unknown compounds (1–6) and another four metabolites previously not described for the genus Commiphora (7, 10, 12, 13) could be identified. Sesquiterpenes 1 and 2 are novel 9,10-seco-eudesmanes and exhibited an unprecedented sesquiterpene carbon skeleton, which is described here for the first time. New compound 3 is an 9,10 seco-guaian and the only peroxide isolated from myrrh so far. Compounds 1, 2, 4, 7–9, 11, 13–16 were tested in an ICAM-1 in vitro assay. Compound 7, as well as the reference compound furanoeudesma-1,3-diene, acted as moderate inhibitors of this adhesion molecule ICAM-1 (IC50: 44.8 and 46.3 μM, respectively). These results give new hints on the activity of sesquiterpenes with regard to ICAM-1 inhibition and possible modes of action of myrrh in anti-inflammatory processes.
Open AccessSesquiterpenes from Myrrh and Their ICAM-1 Inhibitory Activity In Vitro
By using various chromatographic steps (silica flash, CPC, preparative HPLC), 16 sesquiterpenes could be isolated from an ethanolic extract of myrrh resin. Their chemical structures were elucidated by 1D and 2D NMR spectroscopy and HRESIMS. Among them, six previously unknown compounds (1–6) and another four metabolites previously not described for the genus Commiphora (7, 10, 12, 13) could be identified. Sesquiterpenes 1 and 2 are novel 9,10-seco-eudesmanes and exhibited an unprecedented sesquiterpene carbon skeleton, which is described here for the first time. New compound 3 is an 9,10 seco-guaian and the only peroxide isolated from myrrh so far. Compounds 1, 2, 4, 7–9, 11, 13–16 were tested in an ICAM-1 in vitro assay. Compound 7, as well as the reference compound furanoeudesma-1,3-diene, acted as moderate inhibitors of this adhesion molecule ICAM-1 (IC50: 44.8 and 46.3 μM, respectively). These results give new hints on the activity of sesquiterpenes with regard to ICAM-1 inhibition and possible modes of action of myrrh in anti-inflammatory processes.
- Open Access
- 11 July 2020
- Published by MDPI AG in Biomolecules
- Vol. 10 (7) , 1033
Anti-Inflammatory and Barrier-Stabilising Effects of Myrrh, Coffee Charcoal and Chamomile Flower Extract in a Co-Culture Cell Model of the Intestinal Mucosa
Recent clinical evidence suggests the efficacy of a traditional herbal medicinal product containing myrrh (Commiphora molmol Engl.), coffee charcoal (Coffea arabica L.) and chamomile flower dry extract (Matricaria chamomilla L.) in the therapy of inflammatory bowel diseases (IBD). However, the mechanisms of action in this context have not been entirely elucidated. The present study aimed to evaluate the effects of myrrh, coffee charcoal and chamomile flower extract on the inflammatory cross talk between immune and intestinal epithelial cells together with the resulting intestinal barrier disorders. A complex co-culture cell model consisting of intestinal epithelial cell (IEC) monolayers (Caco-2, HT29-MTX-E12) and macrophages (THP-1) was established for the simultaneous investigation of these two IBD characteristics. The lipopolysaccharide (LPS) activation of the macrophages led to a pro-inflammatory mediator release and thereby an inflammatory stimulation of IECs with chemokine release and reduced barrier function. The effects of the individual plant extracts and a ternary combination on inflammatory mediator release (IL-6, TNF, IL-8, MCP-1, PGE2) was quantified by ELISA. The transepithelial electrical resistance (TEER) of IEC monolayers was measured to evaluate the effects on the barrier function. Budesonide served as a positive control. All three plant extracts exhibited anti-inflammatory properties via the inhibition of the inflammatory mediator release to a varying extent. An intestinal barrier stabilising effect was observed for myrrh and coffee charcoal. Myrrh exerted the most distinct pharmacological activity. Dose reducing and synergistic interactions emerged within the threefold combination. Thus, our results provide a mechanistic basis for the use of the herbal combination of myrrh, coffee charcoal and chamomile flower extract in IBD treatment and underline the potential benefits of the phytotherapeutic multi-component/multi-target approach in this complex pathogenesis.
- 11 July 2020
- Published by MDPI AG in Biomolecules
- Vol. 10 (7) , 1033
Open AccessAnti-Inflammatory and Barrier-Stabilising Effects of Myrrh, Coffee Charcoal and Chamomile Flower Extract in a Co-Culture Cell Model of the Intestinal Mucosa
Recent clinical evidence suggests the efficacy of a traditional herbal medicinal product containing myrrh (Commiphora molmol Engl.), coffee charcoal (Coffea arabica L.) and chamomile flower dry extract (Matricaria chamomilla L.) in the therapy of inflammatory bowel diseases (IBD). However, the mechanisms of action in this context have not been entirely elucidated. The present study aimed to evaluate the effects of myrrh, coffee charcoal and chamomile flower extract on the inflammatory cross talk between immune and intestinal epithelial cells together with the resulting intestinal barrier disorders. A complex co-culture cell model consisting of intestinal epithelial cell (IEC) monolayers (Caco-2, HT29-MTX-E12) and macrophages (THP-1) was established for the simultaneous investigation of these two IBD characteristics. The lipopolysaccharide (LPS) activation of the macrophages led to a pro-inflammatory mediator release and thereby an inflammatory stimulation of IECs with chemokine release and reduced barrier function. The effects of the individual plant extracts and a ternary combination on inflammatory mediator release (IL-6, TNF, IL-8, MCP-1, PGE2) was quantified by ELISA. The transepithelial electrical resistance (TEER) of IEC monolayers was measured to evaluate the effects on the barrier function. Budesonide served as a positive control. All three plant extracts exhibited anti-inflammatory properties via the inhibition of the inflammatory mediator release to a varying extent. An intestinal barrier stabilising effect was observed for myrrh and coffee charcoal. Myrrh exerted the most distinct pharmacological activity. Dose reducing and synergistic interactions emerged within the threefold combination. Thus, our results provide a mechanistic basis for the use of the herbal combination of myrrh, coffee charcoal and chamomile flower extract in IBD treatment and underline the potential benefits of the phytotherapeutic multi-component/multi-target approach in this complex pathogenesis.
- Open Access
Salix daphnoides: A Screening for Oligomeric and Polymeric Proanthocyanidins
In the present study, a qualitative analysis of proanthocyanidins (PAs) from an aqueous-methanolic extract of Salix daphnoides VILL. bark is described. Procyanidin B1 (1), B2 (2), B3 (3), B4 (4), C1 (5), epicatechin-(4β→8)-epicatechin-(4β→8)-catechin (6) and epicatechin-(4β→8)-epicatechin-(4β→8)-epicatechin-(4β→8)-catechin (7) have been isolated by a combination of different chromatographic separations on Sephadex® LH-20-, MCI®-, Diol-and RP-18-phases. Mass spectrometry, 1D- and 2D-NMR, circular dichroism and polarimetry were used for their structure elucidation and verification by comparison with the literature. Additionally, two fractions of very polar flavan-3-ols were compared: “regular” polymeric PAs received at the very end of the Sephadex® LH-20 chromatography showing no mobility on silica TLC and “unusual” PAs with the same RF-value but already eluting together with flavonoids in the Sephadex® LH-20 system. These “unusual” PAs were subsequently enriched by centrifugal partition chromatography (CPC). 13C-NMR, polarimetry, thiolysis, acid hydrolysis and phloroglucinol degradation were used to characterize both fractions. Differences in the composition of different flavan-3-ol units and the middle chain length were observed.
Open AccessSalix daphnoides: A Screening for Oligomeric and Polymeric Proanthocyanidins
In the present study, a qualitative analysis of proanthocyanidins (PAs) from an aqueous-methanolic extract of Salix daphnoides VILL. bark is described. Procyanidin B1 (1), B2 (2), B3 (3), B4 (4), C1 (5), epicatechin-(4β→8)-epicatechin-(4β→8)-catechin (6) and epicatechin-(4β→8)-epicatechin-(4β→8)-epicatechin-(4β→8)-catechin (7) have been isolated by a combination of different chromatographic separations on Sephadex® LH-20-, MCI®-, Diol-and RP-18-phases. Mass spectrometry, 1D- and 2D-NMR, circular dichroism and polarimetry were used for their structure elucidation and verification by comparison with the literature. Additionally, two fractions of very polar flavan-3-ols were compared: “regular” polymeric PAs received at the very end of the Sephadex® LH-20 chromatography showing no mobility on silica TLC and “unusual” PAs with the same RF-value but already eluting together with flavonoids in the Sephadex® LH-20 system. These “unusual” PAs were subsequently enriched by centrifugal partition chromatography (CPC). 13C-NMR, polarimetry, thiolysis, acid hydrolysis and phloroglucinol degradation were used to characterize both fractions. Differences in the composition of different flavan-3-ol units and the middle chain length were observed.
- 15 June 2012
- Published by Wiley in Chemistry & Biodiversity
- Vol. 9 (6) , 1077-1083
Novel Phenyl‐1‐benzoxepinols from Butcher's Broom (Rusci rhizoma)
Two novel compounds, (3S)‐2,3‐dihydro‐3‐(4‐hydroxyphenyl)‐1‐benzoxepin‐8‐ol (1; ruscozepine A) and (3S)‐2,3‐dihydro‐3‐(4‐hydroxyphenyl)‐8‐methoxy‐1‐benzoxepin‐7‐ol (2; ruscozepine B) were isolated from butcher's broom (Rusci rhizoma) together with a biosynthetically possible phenylethanoid precursor, hydroxytyrosol (3). The structures were elucidated by spectroscopic methods such as 1D‐ and 2D‐NMR (COSY, HSQC, HMBC, ROESY), and HR‐EI‐MS experiments. The absolute configuration of the ruscozepines was determined by electronic circular dichroism.
- 15 June 2012
- Published by Wiley in Chemistry & Biodiversity
- Vol. 9 (6) , 1077-1083
Novel Phenyl‐1‐benzoxepinols from Butcher's Broom (Rusci rhizoma)
Two novel compounds, (3S)‐2,3‐dihydro‐3‐(4‐hydroxyphenyl)‐1‐benzoxepin‐8‐ol (1; ruscozepine A) and (3S)‐2,3‐dihydro‐3‐(4‐hydroxyphenyl)‐8‐methoxy‐1‐benzoxepin‐7‐ol (2; ruscozepine B) were isolated from butcher's broom (Rusci rhizoma) together with a biosynthetically possible phenylethanoid precursor, hydroxytyrosol (3). The structures were elucidated by spectroscopic methods such as 1D‐ and 2D‐NMR (COSY, HSQC, HMBC, ROESY), and HR‐EI‐MS experiments. The absolute configuration of the ruscozepines was determined by electronic circular dichroism.
- Open Access
- 1 December 2008
- Published by Walter de Gruyter GmbH in Zeitschrift für Naturforschung C
- Vol. 63 (11-12) , 813-820
Bioactive Cycloartane-Type Triterpene Glycosides from Astragalus elongatus
Together with two known cycloartane-type glycosides, askendosides D (3-O-[α-arabinopyranosyl-( 1→2)-β-xylopyranosyl]-6-O-β-xylopyranosyl-cycloastragenol, 2) and G (3-O- [α-arabinopyranosyl-(1→2)-β-xylopyranosyl]-16-O-β-glucopyranosyl-3β,6α,16β,24(R),25- pentahydroxycycloartane, 3), also a new monodesmosidic cycloartane-type glycoside, elongatoside (1), was isolated from the roots of Astragalus elongatus and identified as 3-O- [α-arabinopyranosyl-(1→2)-β-xylopyranosyl]-cycloastragenol. All structures were unambiguously determined by means of spectroscopic and spectrometric methods (1D and 2D NMR, ESI-MS). The isolated compounds were tested for the inhibition of proliferation and ICAM-1 expression in vitro using the human microvascular endothelial cell line (HMEC-1). 1 showed weak activity in the ICAM-1 assay.
- 1 December 2008
- Published by Walter de Gruyter GmbH in Zeitschrift für Naturforschung C
- Vol. 63 (11-12) , 813-820
Open AccessBioactive Cycloartane-Type Triterpene Glycosides from Astragalus elongatus
Together with two known cycloartane-type glycosides, askendosides D (3-O-[α-arabinopyranosyl-( 1→2)-β-xylopyranosyl]-6-O-β-xylopyranosyl-cycloastragenol, 2) and G (3-O- [α-arabinopyranosyl-(1→2)-β-xylopyranosyl]-16-O-β-glucopyranosyl-3β,6α,16β,24(R),25- pentahydroxycycloartane, 3), also a new monodesmosidic cycloartane-type glycoside, elongatoside (1), was isolated from the roots of Astragalus elongatus and identified as 3-O- [α-arabinopyranosyl-(1→2)-β-xylopyranosyl]-cycloastragenol. All structures were unambiguously determined by means of spectroscopic and spectrometric methods (1D and 2D NMR, ESI-MS). The isolated compounds were tested for the inhibition of proliferation and ICAM-1 expression in vitro using the human microvascular endothelial cell line (HMEC-1). 1 showed weak activity in the ICAM-1 assay.